1. Home
  2. ASPN vs ABVX Comparison

ASPN vs ABVX Comparison

Compare ASPN & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • ABVX
  • Stock Information
  • Founded
  • ASPN 2001
  • ABVX 2013
  • Country
  • ASPN United States
  • ABVX France
  • Employees
  • ASPN N/A
  • ABVX N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • ABVX
  • Sector
  • ASPN Consumer Discretionary
  • ABVX
  • Exchange
  • ASPN Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • ASPN 486.5M
  • ABVX 511.3M
  • IPO Year
  • ASPN 2014
  • ABVX N/A
  • Fundamental
  • Price
  • ASPN $6.16
  • ABVX $7.90
  • Analyst Decision
  • ASPN Strong Buy
  • ABVX Buy
  • Analyst Count
  • ASPN 10
  • ABVX 4
  • Target Price
  • ASPN $21.78
  • ABVX $31.50
  • AVG Volume (30 Days)
  • ASPN 1.4M
  • ABVX 273.1K
  • Earning Date
  • ASPN 08-06-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • ASPN N/A
  • ABVX N/A
  • EPS Growth
  • ASPN N/A
  • ABVX N/A
  • EPS
  • ASPN N/A
  • ABVX N/A
  • Revenue
  • ASPN $436,921,000.00
  • ABVX $11,444,012.00
  • Revenue This Year
  • ASPN N/A
  • ABVX $284.20
  • Revenue Next Year
  • ASPN $24.31
  • ABVX N/A
  • P/E Ratio
  • ASPN N/A
  • ABVX N/A
  • Revenue Growth
  • ASPN 51.90
  • ABVX 128.98
  • 52 Week Low
  • ASPN $4.16
  • ABVX $4.77
  • 52 Week High
  • ASPN $33.15
  • ABVX $14.16
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 52.87
  • ABVX 65.02
  • Support Level
  • ASPN $5.75
  • ABVX $7.41
  • Resistance Level
  • ASPN $6.36
  • ABVX $8.06
  • Average True Range (ATR)
  • ASPN 0.31
  • ABVX 0.46
  • MACD
  • ASPN -0.00
  • ABVX 0.11
  • Stochastic Oscillator
  • ASPN 62.13
  • ABVX 90.57

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: